Home - Clinical Trials Arena
WEBModerna blamed after children offered £1,500 to take part in Covid-19 trial. Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue influence. More themes. Artificial Intelligence. Cloud.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 — Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 — With an estimated market value of $37.1bn in 2031, the race for the development of obesity medications is on. Here are some trials to watch.
Biosimilars: top 10 pharma companies leading the way
WEBJan 20, 2022 — Biosimilars: top 10 pharma companies leading the way The analysis is influenced by new biosimilars jobs, deals, patents, and mentions in company reports since January 2021.
Ocrevus (ocrelizumab) for the Treatment of Multiple Sclerosis
WEBOcrevus is a humanised monoclonal antibody that inhibits the growth of the CD20-positive B lymphoma cell lines, which play a major role in damaging nerve cells and the myelin sheath around the nerves. Ocrelizumab selectively targets the CD20-positive B-cells by binding to the surface proteins of the cells and protecting the nerve cells from ...
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
WEBJun 19, 2024 — Mounjaro (tirzepatide) injection is a new dual-targeted therapy indicated for the management of type 2 diabetes in adults.
EU Clinical Trial Regulation: What You Need to Know
WEBMay 20, 2021 — Discover essential insights into the EU Clinical Trial Regulation and its implications. shaping the landscape of clinical trials in Europe.
First patient dosed in BioNTech Phase II trial of mRNA cancer vaccine
WEBJun 18, 2021 — The BioNTech BNT111-01 trial, which is being carried out in collaboration with Regeneron, has dosed the first patient in Europe. The first patient has been treated in a Phase II cancer vaccine trial by BioNTech, evaluating its mRNA-based therapy BNT111 in combination with Libtayo (cemiplimab) in patients with anti-PD1-refractory/relapsed ...
Defining decentralized clinical trials and understanding their nuances
WEBNov 15, 2021 — Defining decentralized clinical trials and understanding their nuances. Juliet Martin November 15, 2021. Decentralization is one arrow in the quiver to modernize clinical trials. [1] Yet, owing to the varied approaches and possible components that can be brought to bear under the rubric of decentralization, a singular and unifying definition is ...
- Some results have been removed